13F filing recap · Q3 2019

What did Brave Warrior Advisors buy in Q3 2019?

Reported stock-position changes between this filing and the previous one.

Stock value

$1.87B

Positions

Estimated turnover

28.0%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

ELVElevance Health, Inc.$153.28Mreported value+638.4K shares

Increased positions

BRK.BBerkshire Hathaway Inc$312.83Mreported value+244.4K shares+19.4%RJFRaymond James Financial Inc$212.34Mreported value+142.5K shares+5.9%PRIPrimerica, Inc.$111.75Mreported value+119.9K shares+15.8%BACBank of America Corp$424.0Kreported value+14 shares

Reduced positions

GOOGLAlphabet Inc.$358.59Mreported value-2.1K shares-0.7%JPMJPMorgan Chase & Co$238.52Mreported value-12.1K shares-0.6%SCHWSchwab Charles Corp$141.38Mreported value-24.9K shares-0.7%LENLennar Corp /new/$140.45Mreported value-859.8K shares

Exited positions

LBTYKLiberty Global Ltd.$123.78Mprior reported value-4.67M shares-100.0%METAMeta Platforms, Inc.$111.51Mprior reported value-577.8K shares-100.0%FTDRFrontdoor, Inc.$1.80Mprior reported value-41.4K shares-100.0%